folic acid has been researched along with Cancer of Prostate in 103 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (2.91) | 18.7374 |
1990's | 3 (2.91) | 18.2507 |
2000's | 27 (26.21) | 29.6817 |
2010's | 56 (54.37) | 24.3611 |
2020's | 14 (13.59) | 2.80 |
Authors | Studies |
---|---|
Augustin, E; Bujak, P; Kasprzak, A; Kowalczyk, A; Kowalik, P; Nowicka, AM; Paluszkiewicz, E; Pilch, J | 1 |
Ghanem, E; Hage, RE; Minassian, G; Rahme, K | 1 |
Chen, J; Chen, X; Deng, H; Hao, S; Wang, Y; Zhai, D; Zhou, Y | 1 |
Chen, J; Liu, S; Wang, Y; Xu, Y | 1 |
Chibane, AA; Khelil, M; Mouhoub-Terrab, R | 1 |
Gul, AR; Kailasa, SK; Kim, MW; Le, TN; Oh, KT; Park, TJ; Phan, LMT | 1 |
Appelhans, D; Boye, S; Daeg, J; Janke, A; Lederer, A; Shi, X; Temme, A; Voit, B; Xu, X; Zhao, J; Zhao, L | 1 |
Changizi, O; Keyvan Rad, J; Khoei, S; Mahdavi, SR; Mahdavian, A; Shirvalilou, S | 1 |
Banerjee, T; Bean, R; Butcher, T; Patel, A; Santra, S; Shaw, Z | 1 |
Moyad, MA | 1 |
Mirsafaei, R; Mirsattari, SN; Varshosaz, J | 1 |
Ashcraft, K; Bacich, D; Liss, MA; Satsangi, A | 1 |
DeCarlo, A; Malardier-Jugroot, C; Szewczuk, MR | 1 |
Baeza, A; Lopez, V; Rodríguez-García, V; Vallet-Regí, M; Villegas, MR | 1 |
Bacich, DJ; Balarin, A; Gutierrez, JM; Liss, MA; Lobitz, CA; O'Keefe, DS; Ullevig, SL | 1 |
Campos-Outcalt, D | 1 |
Ebrahimi, A; Hosseinzadeh Colagar, A; Karimian, M | 1 |
Bastiaansen, JAM; Bonvin, D; Hofmann, H; Mionić Ebersold, M; Stuber, M | 1 |
Darcy, R; Evans, JC; Hollier, BG; Malhotra, M; Nelson, CC; O'Driscoll, CM; Sweeney, K | 1 |
Buys, SS; Gren, LH; Hashibe, M; Kawakita, D; La Vecchia, C; Lee, YA | 1 |
Emerling, BM; Palamiuc, L | 1 |
Arellano, DL; Chauhan, K; Fournier, PGJ; Hirata, GA; Jain, A; Juárez, P; Sengar, P; Verdugo-Meza, A | 1 |
Bacich, DJ; Heston, WDW; Huang, SS; O'Keefe, DS | 1 |
Lillard, JW; Singh, R; Singh, SK | 1 |
Amitay, Y; Gabizon, A; Kumar, S; Ohana, P; Patil, Y; Shmeeda, H | 1 |
Rajput, SJ; Saroj, S | 1 |
Ahmad, I; Ain, MR; Ibrahim, IAA; Md, S; Nassir, AM; Shahzad, N; Waris, M | 1 |
Essén, A; Garmo, H; Hammar, N; Holmberg, L; Jungner, I; Malmström, H; Santaolalla, A; Van Hemelrijck, M; Walldius, G | 1 |
Bjørge, T; de Vogel, S; Fredriksen, Å; Meyer, K; Nygård, O; Tell, GS; Tretli, S; Ueland, PM; Ulvik, A; Vollset, SE | 1 |
Abdeen, S; Alexander, P; Bhagat, M; Chavali, M; Praseetha, PK; Rose, PA | 1 |
Han, YY; Song, JY; Talbott, EO | 1 |
Collin, SM | 1 |
Bacich, DJ; O'Keefe, DS; Rycyna, KJ | 1 |
Carroll, PR; Chan, JM; Davies, BJ; O'Keefe, DS; Richman, EL; Sadetsky, N; Tomaszewski, JJ | 1 |
Andrici, J; Cox, MR; Eslick, GD; Tio, M | 1 |
Huang, JY; Wang, JN; Wang, R; Zhang, AQ; Zheng, Y; Zhou, YH | 1 |
Banerjee, S; Jain, NK; Kesharwani, P; Mehra, NK; Singh, R; Singh, S | 1 |
Hu, QF; Sun, FV; Xia, GW | 1 |
Haldar, MK; Karandish, F; Katti, DR; Katti, KS; Mallik, S; Molla, MS | 1 |
Albanes, D; Allen, NE; Appleby, PN; Barricarte Gurrea, A; Bjørge, T; Bueno-de-Mesquita, HB; Chen, C; de Vogel, S; Donovan, J; Gislefoss, R; Goodman, G; Gunter, M; Hamdy, FC; Johansson, M; Key, TJ; King, IB; Kühn, T; Männistö, S; Martin, RM; Meyer, K; Neal, DE; Neuhouser, ML; Nygård, O; Price, AJ; Stattin, P; Tell, GS; Travis, RC; Trichopoulou, A; Tumino, R; Ueland, PM; Ulvik, A; Vollset, SE; Weinstein, SJ | 1 |
Guo, J; Holmes, JD; O'Driscoll, CM; Rahme, K | 1 |
Darcy, R; Evans, JC; Griffin, BT; Guo, J; Hanrahan, K; Landry, WD; Malhotra, M; O'Driscoll, CM; O'Neill, A; O'Shea, JP; Watson, RW | 1 |
Chang, X; Chao, Z; Zheng-Yan, G | 1 |
Choi, EH; Choi, KH; Jung, JS; Malkinski, L; Nam, KC; Park, BJ | 1 |
Adam, V; Eckschlager, T; Guran, R; Heger, Z; Kizek, R; Kopel, P; Kulich, P; Masarik, M; Merlos Rodrigo, MA; Polanska, H; Stiborova, M | 1 |
Chen, RC; Ji, J; Liu, N; Lu, W; Qiu, H; Shao, Z; Wang, J; Yao, H; Zhang, L; Zhang, X | 1 |
Bacich, DJ; Cummings, JL; O'Keefe, DS; Sobek, KM | 1 |
Amato, RJ; Hartmann, LC; He, W; Kalli, KR; Klee, GG; Kularatne, SA; Low, PS; Prendergast, FG | 1 |
Coogan, P; Palmer, JR; Rosenberg, L; Strom, BL; Zhang, Y | 1 |
Albanes, D | 1 |
Kristal, AR; Lippman, SM | 1 |
Baron, JA; Bresalier, RS; Burke, CA; Figueiredo, JC; Grau, MV; Haile, RW; McKeown-Eyssen, GE; Sandler, RS; Summers, RW | 1 |
Jiang, R; Yuan, S; Zhang, XN; Zhang, Y; Zhao, XH; Zu, YG | 1 |
Al Olama, AA; Benediktsdottir, KR; Chen, L; Collin, SM; Cox, A; Davis, M; Donovan, J; Easton, DF; Eeles, RA; Gudmundsson, J; Guy, M; Hamdy, FC; Kote-Jarai, Z; Lane, JA; Lewis, SJ; Martin, RM; Metcalfe, C; Morrison, J; Neal, DE; Rafnar, T; Smith, GD; Stefansson, K; Sulem, P; Zuccolo, L | 1 |
Bacich, DJ; Berkman, CE; Choi, JK; O'Keefe, DS; Yao, V | 1 |
Farris, P; Forester, A; Garzotto, M; Palma, A; Peters, L; Phoutrides, E; Shannon, J; Tillotson, CJ | 1 |
Baron, JA; Bønaa, KH; Chen, L; Collin, SM; Davis, M; Donovan, JL; Ebbing, M; Grau, MV; Hamdy, FC; Harris, R; Johnston, C; Lane, JA; Lewis, SJ; Marsden, G; Martin, RM; Metcalfe, C; Neal, DE; Nygård, O; Refsum, H; Smith, AD; Smith, GD; Ueland, PM; Zuccolo, L | 1 |
Safarinejad, MR; Safarinejad, S; Shafiei, N | 1 |
Colditz, GA; Wei, EK; Wolin, KY | 1 |
Ambrosini, GL; Beilby, J; de Klerk, NH; Musk, AW; Rossi, E | 1 |
Caberto, C; Cao, X; Harris, R; Hennis, AJ; Leske, MC; Nemesure, B; Pakseresht, M; Sharma, S; Wilkens, LR; Wu, SY | 1 |
Collin, SM; Cox, A; Davis, M; Donovan, JL; Hamdy, FC; Johnston, C; Lane, JA; Lewis, SJ; Marsden, G; Martin, RM; Metcalfe, C; Neal, DE; Refsum, H; Smith, AD; Smith, GD | 1 |
Bu, R; Cai, D; Chen, X; Cheng, Y; Liu, X; Ning, L; Pan, C; Wang, K; Wu, B | 1 |
Jiang, R; Li, J; Zhang, Y; Zhang, Z; Zhao, D; Zhao, X; Zu, Y | 1 |
Luka, Z; Wagner, C | 1 |
Bacich, DJ; Cummings, JL; Dhir, R; Mason, JB; Nelson, JB; O'Keefe, DS; Parwani, AV; Tomaszewski, JJ | 1 |
Bennett, FI; Jackson, MD; Walker, SP; Younger, NM | 1 |
Potter, JD | 1 |
Bakkar, A; Bismar, TA; Brockton, NT; Liu, S; Petersen, LF; Weljie, AM; Wen, J | 1 |
Bistulfi, G; Dhiman, VK; Foster, BA; Gillard, B; Karasik, E; Miecznikowski, J; Smiraglia, DJ | 1 |
Carducci, MA; Herman, JG; Shabbeer, S; Simons, BW; Williams, SA | 1 |
Akadam-Teker, AB; İsbir, T; Küçükhüseyin, Ö; Kurnaz, Ö; Narter, F; Yılmaz-Aydoğan, H | 1 |
Addlagatta, A; Digumarti, RR; Divyya, S; Gottumukkala, SR; Kumar, A; Kutala, VK; Murthy, PV; Naushad, SM; Rammurti, S; Reddy, ChR | 1 |
Baglietto, L; Bassett, JK; English, DR; Giles, GG; Hodge, AM; Hopper, JL; Severi, G | 1 |
Boyarskih, UA; Filipenko, ML; Ganov, DI; Lacarev, AF; Oskina, NA; Petrova, VD; Tonacheva, OG; Voronina, EN; Weiner, AS | 1 |
Cremers, P; Goldbohm, RA; Schouten, LJ; van den Brandt, PA; Verhage, BA | 1 |
Krupenko, NI; Krupenko, SA; Strickland, KC | 1 |
Addlagatta, A; Digumarti, RR; Divyya, S; Gottumukkala, SR; Kutala, VK; Murthy, PV; Naushad, SM; Reddy, ChR; Subbarao, SA | 1 |
Chen, GL; Epner, DE; Kwabi-Addo, B; Lu, S; Ren, C | 1 |
Horne, DW; Reed, KA | 2 |
BEMM, H; ROTZSCH, W; STRACK, E | 1 |
Albanes, D; Barrett, MJ; Hartman, TJ; Pietinen, P; Stolzenberg-Solomon, R; Taylor, PR; Virtamo, J; Weinstein, SJ | 1 |
Ghosh, A; Heston, WD | 1 |
Hattori, Y; Maitani, Y | 2 |
Bergh, A; Hallmans, G; Hultdin, J; Stattin, P; Van Guelpen, B | 1 |
Franceschi, S; Galeone, C; La Vecchia, C; Montella, M; Negri, E; Parpinel, M; Pelucchi, C; Talamini, R | 1 |
Bartholomew, H; Beilby, JP; Divitini, ML; Hung, J; Knuiman, MW; Rossi, E | 1 |
Bergh, AR; Hallmans, G; Hultdin, J; Stattin, PE; Van Guelpen, BR; Wirén, SM | 1 |
Calle, EE; McCullough, ML; Pavluck, AL; Rodriguez, C; Stevens, VL; Thun, MJ | 1 |
Albanes, D; Pietinen, P; Stolzenberg-Solomon, R; Taylor, PR; Virtamo, J; Weinstein, SJ | 1 |
van Guelpen, B | 1 |
Caballero, J; Carnero, J; Diaz, F; Gaitan, MJ; Machuca, J; Marchal, C; Perea-Milla, E; Redondo, M; Reyes-Engel, A | 1 |
Allen, NE; Appleby, PN; Ardanaz, E; Bingham, S; Boeing, H; Bueno-de-Mesquita, HB; Chirlaque, MD; Egevad, L; González, CA; Hallmans, G; Jenab, M; Johansson, M; Kaaks, R; Key, TJ; Khaw, KT; Kiemeney, LA; Larrañaga, N; Linseisen, J; Palli, D; Pischon, T; Psaltopoulou, T; Quirós, JR; Riboli, E; Rinaldi, S; Roddam, AW; Sánchez, MJ; Sieri, S; Stattin, P; Travis, RC; Trichopoulos, D; Trichopoulou, A; Tumino, R; Ueland, PM; Vineis, P; Vollset, SE | 1 |
Barczak, AK; Coyle, JT; Luthi-Carter, R; Speno, H | 1 |
Berzin, TM; Heston, WD; Lin, S; May, F; Mukherjee, B; Pinto, JT; Qiao, CH; Suffoletto, BP; Tong, WP | 1 |
Andersson, C; O'Brien, NM; Wild, CP; Wilson, L; Woods, JA | 1 |
Krupenko, SA; Oleinik, NV | 1 |
Fairfield, KM; Fletcher, RH | 1 |
Andersson, A; Brattström, L; Hultberg, B; Israelsson, B; Olsson, A | 1 |
Jansen, SE; Joubert, M; Retief, FP | 1 |
Bloom, HJ; Wallace, DM; Williams, G | 1 |
16 review(s) available for folic acid and Cancer of Prostate
Article | Year |
---|---|
Effect of dietary antioxidants on the risk of prostate cancer. Systematic review and network meta-analysis.
Topics: Antioxidants; Folic Acid; Humans; Male; Network Meta-Analysis; Prostatic Neoplasms; Vitamins | 2023 |
Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and "First Do No Harm" Part II.
Topics: Cardiovascular Diseases; Diet; Dietary Supplements; Fish Oils; Folic Acid; Food; Health Status; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Male; Prescription Drugs; Prostatic Neoplasms; Quality Control; Risk Reduction Behavior; Vitamin B 12 | 2020 |
A Perspective on the Evolving Story of PSMA Biology, PSMA-Based Imaging, and Endoradiotherapeutic Strategies.
Topics: Diagnostic Imaging; Folic Acid; Glutamate Carboxypeptidase II; Humans; Male; Molecular Targeted Therapy; Prostatic Neoplasms; Radiotherapy | 2018 |
Folate and B12 in prostate cancer.
Topics: Betaine; Diet; Dietary Supplements; Folic Acid; Homocysteine; Humans; Male; Meta-Analysis as Topic; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Vitamin B 12 | 2013 |
Opposing roles of folate in prostate cancer.
Topics: Animals; Carcinogenesis; Cell Line, Tumor; Disease Progression; Folic Acid; Folic Acid Deficiency; Humans; Immunohistochemistry; Kallikreins; Male; Nutrition Surveys; Prostate-Specific Antigen; Prostatic Neoplasms; Vitamin B Complex | 2013 |
Folate intake and the risk of prostate cancer: a systematic review and meta-analysis.
Topics: Diet; Dietary Supplements; Folic Acid; Humans; Male; Odds Ratio; Prostatic Neoplasms; Risk | 2014 |
Folate intake, serum folate levels, and prostate cancer risk: a meta-analysis of prospective studies.
Topics: Carcinoma; Diet; Folic Acid; Humans; Incidence; Male; Odds Ratio; Prospective Studies; Prostatic Neoplasms; Risk | 2014 |
[Roles of folate metabolism in prostate cancer].
Topics: Dietary Supplements; Disease Progression; Folic Acid; Food, Fortified; Humans; Male; Nutrition Surveys; Nutritional Status; Prostatic Neoplasms | 2015 |
Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Case-Control Studies; Folic Acid; Genetic Predisposition to Disease; Glutamate Carboxypeptidase II; Glycine Hydroxymethyltransferase; Humans; Male; Methylenetetrahydrofolate Dehydrogenase (NADP); Methylenetetrahydrofolate Reductase (NADPH2); Minor Histocompatibility Antigens; Polymorphism, Genetic; Prostatic Neoplasms; Risk Factors | 2009 |
Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis.
Topics: Aged; Case-Control Studies; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Transcobalamins; Vitamin B 12 | 2010 |
Time course of risk factors in cancer etiology and progression.
Topics: Alcohol Drinking; Breast Neoplasms; Colorectal Neoplasms; Diet; Disease Progression; Female; Folic Acid; Humans; Lung Neoplasms; Male; Neoplasms; Prognosis; Prostatic Neoplasms; Risk Factors; Smoking | 2010 |
Molecular mechanisms underlying the potentially adverse effects of folate.
Topics: Cell Transformation, Neoplastic; Dietary Supplements; Folic Acid; Folic Acid Deficiency; Humans; Male; Neoplasm Metastasis; Neoplasms; Neural Tube Defects; Prostatic Neoplasms; Tetrahydrofolate Dehydrogenase | 2013 |
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.
Topics: Alternative Splicing; Animals; Antigens, Surface; Contractile Proteins; Dipeptides; Endocytosis; Enhancer Elements, Genetic; Filamins; Folic Acid; Gene Expression Regulation, Neoplastic; Glutamate Carboxypeptidase II; Humans; Male; Mice; Microfilament Proteins; Models, Biological; Prostatic Neoplasms; Receptors, Androgen | 2004 |
Folate in colorectal cancer, prostate cancer and cardiovascular disease.
Topics: Colorectal Neoplasms; Female; Folic Acid; Folic Acid Deficiency; Humans; Male; Myocardial Infarction; Prostatic Neoplasms; Sweden; Vitamin B Complex | 2007 |
A critical evaluation of the application of biomarkers in epidemiological studies on diet and health.
Topics: Biomarkers; Colorectal Neoplasms; Cooking; Diet; Epidemiologic Factors; Estrogens, Non-Steroidal; Female; Folic Acid; Genetic Predisposition to Disease; Genistein; Health Surveys; Heterocyclic Compounds; Humans; Iodine; Isoflavones; Male; Meat; Middle Aged; Neural Tube Defects; Nutritional Status; Phytoestrogens; Plant Preparations; Predictive Value of Tests; Pregnancy; Prostatic Neoplasms; Risk Factors; Specimen Handling; Vitamin D | 2001 |
Vitamins for chronic disease prevention in adults: scientific review.
Topics: Ascorbic Acid; Avitaminosis; Blood Coagulation; Breast Neoplasms; Carotenoids; Chronic Disease; Colorectal Neoplasms; Coronary Disease; Dietary Supplements; Female; Folic Acid; Fractures, Bone; Humans; Lung Neoplasms; Male; Neoplasms; Neural Tube Defects; Prostatic Neoplasms; Risk Factors; Vitamin A; Vitamin B 12; Vitamin B 6; Vitamin D; Vitamin E; Vitamin K; Vitamins | 2002 |
3 trial(s) available for folic acid and Cancer of Prostate
Article | Year |
---|---|
Feasibility of dietary folic acid reduction intervention for men on active surveillance for prostate cancer.
Topics: Feasibility Studies; Folic Acid; Humans; Male; Pilot Projects; Prostatic Neoplasms; Watchful Waiting | 2021 |
Folic acid and risk of prostate cancer: results from a randomized clinical trial.
Topics: Adenoma; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colorectal Neoplasms; Cyclooxygenase Inhibitors; Dietary Supplements; Double-Blind Method; Folic Acid; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Prostatic Neoplasms; Research Design; Surveys and Questionnaires; United States; Vitamin B Complex | 2009 |
Serum levels of folate, lycopene, β-carotene, retinol and vitamin E and prostate cancer risk.
Topics: Aged; beta Carotene; Carotenoids; Case-Control Studies; Cohort Studies; Folic Acid; Humans; Lycopene; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Vitamin A; Vitamin E | 2010 |
84 other study(ies) available for folic acid and Cancer of Prostate
Article | Year |
---|---|
Foliate-Targeting Quantum Dots-
Topics: Acridines; Antineoplastic Agents; beta-Cyclodextrins; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Lung; Lung Neoplasms; Male; Nanoconjugates; Nanostructures; Prostate; Prostatic Neoplasms; Quantum Dots | 2022 |
Gold Nanoparticles Conjugated with Dendrigraft Poly-L-lysine and Folate-Targeted Poly(ethylene glycol) for siRNA Delivery to Prostate cancer.
Topics: Folic Acid; Gold; Humans; Male; Metal Nanoparticles; Polyethylene Glycols; Polylysine; Prostatic Neoplasms; RNA, Small Interfering | 2023 |
In vitro and in vivo Evaluation of Folic Acid Modified DOX-Loaded
Topics: Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Male; Nanoparticles; Polyethylene Glycols; Prostate; Prostatic Neoplasms | 2023 |
No association between MTHFR gene C677T/A1298C polymorphisms, serum folate, vitamin B12, homocysteine levels, and prostate cancer in an Algerian population.
Topics: Case-Control Studies; Folic Acid; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Prostatic Neoplasms; Vitamin B 12 | 2023 |
One-pot synthesis of carbon dots with intrinsic folic acid for synergistic imaging-guided photothermal therapy of prostate cancer cells.
Topics: Antigens, Surface; Carbon; Cell Line, Tumor; Cell Proliferation; Cell Survival; Folic Acid; Glutamate Carboxypeptidase II; Humans; Hyperthermia, Induced; Indoles; Male; Microscopy, Fluorescence; Nanoparticles; Phototherapy; Polymers; Prostatic Neoplasms | 2019 |
Bivalent Peptide- and Chelator-Containing Bioconjugates as Toolbox Components for Personalized Nanomedicine.
Topics: Animals; Antigens, Surface; Avidin; Biotin; Chelating Agents; Contrast Media; Dendrimers; Diagnostic Imaging; ErbB Receptors; Folic Acid; Glutamate Carboxypeptidase II; HEK293 Cells; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice, Inbred BALB C; Molecular Targeted Therapy; Nanomedicine; Peptides; Polyethylene Glycols; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2020 |
Enhanced radiosensitivity of LNCaP prostate cancer cell line by gold-photoactive nanoparticles modified with folic acid.
Topics: Cell Line, Tumor; Cell Survival; Folic Acid; Gold; Humans; Male; Metal Nanoparticles; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Radiation Tolerance | 2020 |
Pseudo-branched polyester copolymer: an efficient drug delivery system to treat cancer.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Folic Acid; Humans; Male; Microscopy, Fluorescence; Molecular Weight; Nanoparticles; PC-3 Cells; Polymers; Prostatic Neoplasms; Reactive Oxygen Species | 2020 |
Folate-Targeted Polyacrylamide/Punicic Acid Nanomicelles for Flutamide Delivery in Prostate Cancer: Characterization, In Vitro Biological Evaluation, and its DFT Study.
Topics: Acrylic Resins; Cell Death; Cell Line, Tumor; Density Functional Theory; Drug Delivery Systems; Fluorescence; Flutamide; Folic Acid; Humans; Linolenic Acids; Male; Micelles; Molecular Conformation; Nanoparticles; Particle Size; Prostatic Neoplasms; Proton Magnetic Resonance Spectroscopy; Spectroscopy, Fourier Transform Infrared | 2020 |
Rise in serum folate after androgen deprivation associated with worse prostate cancer-specific survival.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Animals; Disease Models, Animal; Folic Acid; Humans; Male; Mice; Mice, Inbred C57BL; Orchiectomy; Prostatic Neoplasms; Retrospective Studies; Survival Rate | 2020 |
Folic Acid-Functionalized Nanomedicine: Folic Acid Conjugated Copolymer and Folate Receptor Interactions Disrupt Receptor Functionality Resulting in Dual Therapeutic Anti-Cancer Potential in Breast and Prostate Cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Folate Receptor 1; Folic Acid; Humans; Male; Nanomedicine; Polymers; Pregnancy; Prostatic Neoplasms; Protein Binding | 2021 |
Janus-Type Mesoporous Silica Nanoparticles for Sequential Tumoral Cell and Mitochondria Targeting.
Topics: Animals; Cell Line, Tumor; Drug Delivery Systems; Folate Receptors, GPI-Anchored; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mitochondria; Nanoparticles; Organophosphorus Compounds; Porosity; Prostatic Neoplasms; Silicon Dioxide | 2021 |
USPSTF recommendations: A 2017 roundup.
Topics: Advisory Committees; Aspirin; Breast Feeding; Cardiovascular Diseases; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Latent Tuberculosis; Male; Mass Screening; Neural Tube Defects; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pregnancy; Primary Health Care; Primary Prevention; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Assessment; Syphilis; United States; Vitamin B Complex | 2017 |
Association of Human Methionine Synthase-A2756G Transition With Prostate Cancer: A Case-Control Study and in Silico Analysis.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Alleles; Case-Control Studies; Folic Acid; Genetic Predisposition to Disease; Genotype; Humans; Iran; Male; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prostatic Neoplasms | 2017 |
Folic acid on iron oxide nanoparticles: platform with high potential for simultaneous targeting, MRI detection and hyperthermia treatment of lymph node metastases of prostate cancer.
Topics: Cell Line, Tumor; Cell Survival; Ferric Compounds; Folic Acid; Humans; Hyperthermia, Induced; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Microscopy, Electron, Transmission; Prostatic Neoplasms; Spectroscopy, Fourier Transform Infrared | 2017 |
Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumours.
Topics: Cell Line, Tumor; Cyclodextrins; Folic Acid; Humans; Male; Nanoparticles; Neuropilin-1; Peptides; Prostatic Neoplasms; RNA, Small Interfering; Spheroids, Cellular; Zinc Finger E-box-Binding Homeobox 1 | 2017 |
The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort.
Topics: Aged; Cohort Studies; Colorectal Neoplasms; Diet; Early Detection of Cancer; Female; Folic Acid; Food, Fortified; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Prospective Studies; Prostatic Neoplasms; United States | 2018 |
PSMA brings new flavors to PI3K signaling: A role for glutamate in prostate cancer.
Topics: Antigens, Surface; Folic Acid; Glutamic Acid; Humans; Male; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Receptors, Metabotropic Glutamate | 2018 |
Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Folic Acid; Luminescent Agents; Male; Mice; Nanocomposites; Nanoparticles; Neoplasms; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Protoporphyrins; Reactive Oxygen Species; Silicon Dioxide; Yttrium | 2018 |
Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Folic Acid; Humans; Male; Nanoparticles; Prostatic Neoplasms; Resveratrol | 2018 |
Targeting of folate-conjugated liposomes with co-entrapped drugs to prostate cancer cells via prostate-specific membrane antigen (PSMA).
Topics: Antigens, Surface; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Delivery Systems; Folic Acid; Glutamate Carboxypeptidase II; Humans; Liposomes; Male; Mitomycin; Prostatic Neoplasms | 2018 |
Etoposide encased folic acid adorned mesoporous silica nanoparticles as potent nanovehicles for enhanced prostate cancer therapy: synthesis, characterization, cellular uptake and biodistribution.
Topics: Cell Line, Tumor; Drug Carriers; Etoposide; Folic Acid; Humans; Male; Nanoparticles; Prostatic Neoplasms; Silicon Dioxide | 2018 |
Surface functionalized folate targeted oleuropein nano-liposomes for prostate tumor targeting: Invitro and invivo activity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Liberation; Folic Acid; Humans; Iridoid Glucosides; Iridoids; Liposomes; Male; Mice; Mice, Inbred BALB C; Particle Size; Prostatic Neoplasms | 2019 |
Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cohort Studies; Diet; Female; Folic Acid; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Risk; Sweden; Vitamin B 12 | 2019 |
Serum folate and vitamin B12 concentrations in relation to prostate cancer risk--a Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort.
Topics: Adult; Aged; Case-Control Studies; Confidence Intervals; Folic Acid; Genotype; Homocysteine; Humans; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Norway; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Population Surveillance; Prospective Studies; Prostatic Neoplasms; Risk Factors; Socioeconomic Factors; Vitamin B 12 | 2013 |
Drug embedded PVP coated magnetic nanoparticles for targeted killing of breast cancer cells.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Chemistry, Pharmaceutical; Coated Materials, Biocompatible; Drug Delivery Systems; Epirubicin; Female; Folic Acid; Humans; Leukemia; Lung Neoplasms; Magnetite Nanoparticles; Male; Pharmaceutic Aids; Povidone; Prostatic Neoplasms; Spectroscopy, Fourier Transform Infrared | 2013 |
Serum folate and prostate-specific antigen in the United States.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Cross-Sectional Studies; Folic Acid; Follow-Up Studies; Humans; Male; Middle Aged; Nutrition Surveys; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; United States | 2013 |
Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™.
Topics: Adenocarcinoma; Aged; Folic Acid; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Prostatic Neoplasms | 2014 |
Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Compounding; Drug Delivery Systems; Endocytosis; Female; Folic Acid; Humans; Lactic Acid; Male; MCF-7 Cells; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostatic Neoplasms; Saquinavir | 2015 |
Sequential culture on biomimetic nanoclay scaffolds forms three-dimensional tumoroids.
Topics: Alkaline Phosphatase; Aluminum Silicates; Biomimetic Materials; Cell Culture Techniques; Cell Differentiation; Cell Proliferation; Cell Survival; Clay; Drug Delivery Systems; Folic Acid; Humans; Male; Mesenchymal Stem Cells; Nanoparticles; Osteoblasts; Osteogenesis; Prostatic Neoplasms; Spheroids, Cellular; Tissue Scaffolds; Tumor Cells, Cultured | 2016 |
Circulating Folate and Vitamin B
Topics: Aged; Case-Control Studies; Cohort Studies; Folic Acid; Hexetidine; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Prostatic Neoplasms; Risk; Vitamin B 12 | 2016 |
Bioconjugated gold nanoparticles enhance cellular uptake: A proof of concept study for siRNA delivery in prostate cancer cells.
Topics: Cell Line, Tumor; Chemistry, Pharmaceutical; Folic Acid; Gene Silencing; Gene Transfer Techniques; Genetic Therapy; Gold; Humans; Male; Metal Nanoparticles; Polyethylene Glycols; Prostate; Prostatic Neoplasms; RNA, Small Interfering | 2016 |
Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo.
Topics: Cell Line, Tumor; Cyclodextrins; Folic Acid; Gene Silencing; Humans; Male; Nanoparticles; Prostatic Neoplasms; RNA, Small Interfering | 2016 |
Re: Alison J. Price, Ruth C. Travis, Paul N. Appleby, et al. Circulating Folate and Vitamin B
Topics: Folic Acid; Humans; Male; Prostatic Neoplasms; Risk; Vitamin B 12 | 2017 |
Size-Dependent Photodynamic Anticancer Activity of Biocompatible Multifunctional Magnetic Submicron Particles in Prostate Cancer Cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cobalt; Contrast Media; Ferric Compounds; Folic Acid; Hematoporphyrins; Humans; Magnetic Fields; Magnetic Resonance Imaging; Male; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms | 2016 |
Prostate tumor attenuation in the nu/nu murine model due to anti-sarcosine antibodies in folate-targeted liposomes.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Folic Acid; Humans; Liposomes; Male; Metallothionein; Mice; Models, Biological; Phosphatidylethanolamines; Prostatic Neoplasms; Sarcosine; Tumor Burden; Xenograft Model Antitumor Assays; Zinc | 2016 |
Folate-targeted nanoparticle delivery of androgen receptor shRNA enhances the sensitivity of hormone-independent prostate cancer to radiotherapy.
Topics: Androgen Receptor Antagonists; Animals; Cell Line, Tumor; Folic Acid; Humans; Male; Mice; Mice, Nude; Nanoparticles; Prostatic Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; RNA, Small Interfering; Xenograft Model Antitumor Assays | 2017 |
Contrasting roles of the ABCG2 Q141K variant in prostate cancer.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Docetaxel; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Male; MicroRNAs; Neoplasm Proteins; Neoplasm Recurrence, Local; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Taxoids | 2017 |
Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands.
Topics: Case-Control Studies; Double-Blind Method; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Folic Acid; Humans; KB Cells; Ligands; Male; Neoplastic Cells, Circulating; Ovarian Neoplasms; Prostatic Neoplasms; Sensitivity and Specificity | 2008 |
Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study.
Topics: Adult; Aged; beta Carotene; Case-Control Studies; Dietary Supplements; Folic Acid; Humans; Male; Middle Aged; Odds Ratio; Prostatic Neoplasms; Risk Factors; Vitamin E; Vitamins; Zinc | 2009 |
Vitamin supplements and cancer prevention: where do randomized controlled trials stand?
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Colorectal Neoplasms; Confounding Factors, Epidemiologic; Dietary Supplements; Female; Folic Acid; Humans; Incidence; Lung Neoplasms; Male; Neoplasms; Primary Prevention; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Assessment; Selenium; United States; Vitamin B 12; Vitamin B 6; Vitamin E | 2009 |
Nutritional prevention of cancer: new directions for an increasingly complex challenge.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Trials as Topic; Cohort Studies; Cooperative Behavior; Dietary Supplements; Folic Acid; Humans; Interdisciplinary Communication; Male; Prostatic Neoplasms; Research Design; Risk Factors; Vitamin B Complex | 2009 |
[Preparation, activity and targeting ability evaluation in vitro on folate mediated epigallocatechin-3-gallate albumin nanoparticles].
Topics: Antineoplastic Agents, Phytogenic; Catechin; Cell Death; Cell Line, Tumor; Drug Carriers; Drug Compounding; Drug Delivery Systems; Folic Acid; Humans; Male; Nanoparticles; Particle Size; Prostatic Neoplasms; Serum Albumin, Bovine | 2009 |
Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid.
Topics: Antigens, Surface; Cell Line, Tumor; Cell Proliferation; Dipeptides; Folic Acid; Glutamate Carboxypeptidase II; Humans; Hydrolysis; Male; Organophosphorus Compounds; Prostatic Neoplasms; Pteroylpolyglutamic Acids | 2010 |
Folate intake and prostate cancer risk: a case-control study.
Topics: Aged; Aged, 80 and over; Alcohol Drinking; Biopsy; Body Mass Index; Case-Control Studies; Confidence Intervals; Diet; Diet Surveys; Folic Acid; Humans; Male; Matched-Pair Analysis; Middle Aged; Odds Ratio; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; United States; Veterans | 2009 |
Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.
Topics: Adult; Aged; Case-Control Studies; Cystamine; DNA; Folic Acid; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Prostate-Specific Antigen; Prostatic Neoplasms; Vitamin B 12 | 2010 |
Validation of a quantitative FFQ for the Barbados National Cancer Study.
Topics: Adult; Aged; Aged, 80 and over; Barbados; Black People; Breast Neoplasms; Case-Control Studies; Cross-Sectional Studies; Diet; Diet Records; Diet Surveys; Dietary Fiber; Evaluation Studies as Topic; Feeding Behavior; Female; Folic Acid; Humans; Male; Middle Aged; Nutrition Assessment; Prostatic Neoplasms; Surveys and Questionnaires; Vitamin A; Vitamin B 12; Vitamin E; Vitamins | 2011 |
Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer.
Topics: Aged; Biomarkers, Tumor; Disease Progression; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Prostate-Specific Antigen; Prostatic Neoplasms; Signal Transduction; Vitamin B 12 | 2010 |
Association of polymorphisms in folate metabolic genes and prostate cancer risk: a case-control study in a Chinese population.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Aged, 80 and over; Alleles; Case-Control Studies; China; Ferredoxin-NADP Reductase; Folic Acid; Genetic Linkage; Genotype; Haplotypes; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Prostatic Hyperplasia; Prostatic Neoplasms | 2010 |
Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cattle; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Stability; Folic Acid; Humans; In Vitro Techniques; Male; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanoparticles; Paclitaxel; Particle Size; Prostatic Neoplasms; Serum Albumin, Bovine; Solubility; Surface Properties | 2010 |
Sarcosine, folate metabolism and prostate cancer--is there a link?
Topics: Biomarkers, Tumor; Case-Control Studies; Folic Acid; Humans; Male; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Prostatic Neoplasms; Reference Values; Sarcosine; Sensitivity and Specificity | 2011 |
Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate.
Topics: Adult; Aged; Carcinoma; Cell Proliferation; Fasting; Folic Acid; Humans; Immunohistochemistry; Incidence; Ki-67 Antigen; Male; Middle Aged; Osmolar Concentration; Prostatic Neoplasms; Staining and Labeling | 2011 |
Use of a food frequency questionnaire to assess diets of Jamaican adults: validation and correlation with biomarkers.
Topics: Adult; Aged; Biomarkers; Calibration; Case-Control Studies; Cholesterol; Diet; Dietary Fats; Dietary Proteins; Energy Intake; Feeding Behavior; Female; Folic Acid; Humans; Jamaica; Male; Middle Aged; Prostatic Neoplasms; Regression Analysis; Reproducibility of Results; Surveys and Questionnaires; Vitamin A; Vitamin E | 2011 |
New Zealand should have mandatory fortification of bread with folic acid: no.
Topics: Bread; Colorectal Neoplasms; Folic Acid; Food, Fortified; Humans; Male; Neural Tube Defects; New Zealand; Nutrition Policy; Prostatic Neoplasms; Risk | 2010 |
Elevated physiological levels of folic acid can increase in vitro growth and invasiveness of prostate cancer cells.
Topics: Cell Proliferation; Folic Acid; Humans; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Sarcosine; Tumor Cells, Cultured | 2012 |
Dietary folate deficiency blocks prostate cancer progression in the TRAMP model.
Topics: Animals; Apoptosis; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; CpG Islands; Diet; Disease Models, Animal; Disease Progression; DNA Methylation; Folic Acid; Folic Acid Deficiency; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Prostate; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; RNA, Messenger | 2011 |
Progression of prostate carcinogenesis and dietary methyl donors: temporal dependence.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Transformation, Neoplastic; Choline; Decitabine; Diet; Disease Progression; DNA Methylation; Folic Acid; Homocysteine; Humans; Male; Methionine; Mice; Mice, Nude; Prostatic Neoplasms; Tumor Cells, Cultured; Vitamin B 6 | 2012 |
Effects of the MTHFR C677T polymorphism on prostate specific antigen and prostate cancer.
Topics: Aged; Alleles; Binding Sites; Exons; Folic Acid; Genetic Predisposition to Disease; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms | 2011 |
Paradoxical role of C1561T glutamate carboxypeptidase II (GCPII) genetic polymorphism in altering disease susceptibility.
Topics: Abortion, Spontaneous; Antigens, Surface; Autistic Disorder; Breast Neoplasms; Cohort Studies; Coronary Artery Disease; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Glutamate Carboxypeptidase II; Humans; Male; Polymorphism, Genetic; Prostatic Neoplasms | 2012 |
Dietary intake of B vitamins and methionine and prostate cancer incidence and mortality.
Topics: Adult; Aged; Aged, 80 and over; Australia; Cohort Studies; Confidence Intervals; Female; Folic Acid; Follow-Up Studies; Humans; Incidence; Male; Methionine; Middle Aged; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Riboflavin; Risk Factors; Surveys and Questionnaires; Vitamin B Complex | 2012 |
Role of polymorphic variants of MTR gene A2756G and SHMT1 gene C1420T in the development of prostatic cancer in residents of the Western Siberian Region of Russia.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Alleles; Case-Control Studies; Folic Acid; Gene Frequency; Genetic Loci; Genotype; Glycine Hydroxymethyltransferase; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Risk Factors; Siberia; White People | 2012 |
Dietary folate and folate vitamers and the risk of prostate cancer in The Netherlands Cohort Study.
Topics: Aged; Cohort Studies; Folic Acid; Humans; Male; Middle Aged; Netherlands; Prostatic Neoplasms; Risk Factors; Surveys and Questionnaires | 2012 |
Association of glutamate carboxypeptidase II (GCPII) haplotypes with breast and prostate cancer risk.
Topics: Adult; Aged; Antigens, Surface; Breast Neoplasms; Case-Control Studies; Female; Folic Acid; Gene Expression Regulation, Neoplastic; Glutamate Carboxypeptidase II; Haplotypes; Humans; Male; Middle Aged; Prostatic Neoplasms; Protein Conformation; Risk Factors; Young Adult | 2013 |
Methionine restriction selectively targets thymidylate synthase in prostate cancer cells.
Topics: Antimetabolites, Antineoplastic; Cell Division; Fluorouracil; Folic Acid; Humans; Male; Methionine; Nucleotides; Prostatic Neoplasms; Thymidylate Synthase; Tumor Cells, Cultured | 2003 |
Uptake of 5-methyltetrahydrofolate into PC-3 human prostate cancer cells is carrier-mediated.
Topics: Arsenates; Biological Transport; Carrier Proteins; Folic Acid; Humans; Hydrogen-Ion Concentration; Leucovorin; Male; Methotrexate; Phosphates; Prostatic Neoplasms; Sodium; Sodium Azide; Sodium Cyanide; Sulfates; Tetrahydrofolates; Tumor Cells, Cultured | 2003 |
[TRIMETHYLAMINE AND TRIMETHYLAMINE OXIDE IN THE URINE AFTER THE ADMINISTRATION OF N-14- AND N-15-(-) CARNITINE].
Topics: Amines; Body Fluids; Carnitine; Folic Acid; Humans; Hyperthyroidism; Male; Methylamines; Nitrogen; Prostatic Neoplasms; Radioisotopes; Urine; Vitamin B Complex | 1963 |
Null association between prostate cancer and serum folate, vitamin B(6), vitamin B(12), and homocysteine.
Topics: Aged; Case-Control Studies; Diet; Dietary Supplements; DNA Methylation; DNA Repair; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Vitamin B 12; Vitamin B 6 | 2003 |
Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer.
Topics: Cell Line, Tumor; DNA; Folic Acid; Genetic Therapy; Humans; Male; Mouth Neoplasms; Nanostructures; Particle Size; Prostatic Neoplasms; Transfection | 2004 |
Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study.
Topics: Adult; Aged; Bone Neoplasms; Case-Control Studies; Folic Acid; Homocysteine; Humans; Lymphatic Metastasis; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Risk Factors; Sweden; Vitamin B 12 | 2005 |
Dietary folate and risk of prostate cancer in Italy.
Topics: Aged; Alcohol Drinking; Case-Control Studies; Diet; Energy Intake; Folic Acid; Folic Acid Deficiency; Humans; Italy; Logistic Models; Male; Middle Aged; Nutritional Status; Prostatic Neoplasms; Risk Factors | 2005 |
Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase.
Topics: Chromatography, High Pressure Liquid; Connexin 43; DNA Primers; Flow Cytometry; Fluorescein-5-isothiocyanate; Folic Acid; Gene Transfer Techniques; Genes, Transgenic, Suicide; Genetic Therapy; Genetic Vectors; Humans; Immunohistochemistry; Luciferases; Male; Nanostructures; Nasopharyngeal Neoplasms; Plasmids; Prostatic Neoplasms; Simplexvirus; Thymidine Kinase | 2005 |
Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia.
Topics: Adult; Aged; Aged, 80 and over; Australia; Breast Neoplasms; Cohort Studies; Colorectal Neoplasms; Female; Folic Acid; Humans; Male; Middle Aged; Morbidity; Mortality; Neoplasms; Prospective Studies; Prostatic Neoplasms | 2006 |
Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case-control study.
Topics: Adult; Case-Control Studies; Folic Acid; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Polymorphism, Genetic; Prospective Studies; Prostatic Neoplasms; Risk; Sweden; Vitamin B 12 | 2006 |
Folate nutrition and prostate cancer incidence in a large cohort of US men.
Topics: Aged; Diet; Folic Acid; Humans; Incidence; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Risk Factors; Surveys and Questionnaires; United States | 2006 |
Dietary factors of one-carbon metabolism and prostate cancer risk.
Topics: Aged; Alcohol Drinking; alpha-Tocopherol; beta Carotene; Carbon; Case-Control Studies; Dietary Supplements; Double-Blind Method; Ethanol; Finland; Folic Acid; Humans; Male; Methionine; Middle Aged; One-Carbon Group Transferases; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Smoking; Vitamin B 12; Vitamin B 6 | 2006 |
Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Case-Control Studies; Ferredoxin-NADP Reductase; Folic Acid; Genetic Predisposition to Disease; Genotype; Humans; Logistic Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Multivariate Analysis; Polymorphism, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Spain | 2008 |
Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition study.
Topics: Case-Control Studies; Chi-Square Distribution; Europe; Folic Acid; Humans; Incidence; Logistic Models; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Registries; Risk Factors; Surveys and Questionnaires; Vitamin B 12 | 2008 |
Hydrolysis of the neuropeptide N-acetylaspartylglutamate (NAAG) by cloned human glutamate carboxypeptidase II.
Topics: Animals; Antigens, Surface; Binding, Competitive; Carboxypeptidases; Chelating Agents; Cloning, Molecular; Cobalt; Coumarins; Dipeptides; Edetic Acid; Folic Acid; Glutamate Carboxypeptidase II; Histamine H1 Antagonists; Humans; Hydrolysis; Isocoumarins; Kinetics; Leucine; Male; Neuropeptides; Pepstatins; Phenanthrolines; Prostatic Neoplasms; Protease Inhibitors; Rats; Serine Proteinase Inhibitors; Substrate Specificity; Synaptic Transmission; Tumor Cells, Cultured | 1998 |
Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.
Topics: Antigens, Surface; Carboxypeptidases; Cell Fractionation; Cell Membrane; Folic Acid; gamma-Glutamyl Hydrolase; Glutamate Carboxypeptidase II; Humans; Hydrogen-Ion Concentration; Hydrolases; Immunohistochemistry; Male; Methotrexate; Polyglutamic Acid; Prostatic Neoplasms; Pteroylpolyglutamic Acids; Substrate Specificity; Tumor Cells, Cultured | 1996 |
Transport of methotrexate into PC-3 human prostate cancer cells.
Topics: Binding, Competitive; Biological Transport, Active; Buffers; Carrier Proteins; Chlorides; Folic Acid; Humans; Hydrogen-Ion Concentration; Kinetics; Male; Methotrexate; Prostatic Neoplasms; Tumor Cells, Cultured | 2001 |
10-formyltetrahydrofolate dehydrogenase, one of the major folate enzymes, is down-regulated in tumor tissues and possesses suppressor effects on cancer cells.
Topics: Adenocarcinoma; Cell Division; Cell Line, Transformed; Down-Regulation; Folic Acid; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Liver Regeneration; Lung Neoplasms; Male; Oxidoreductases Acting on CH-NH Group Donors; Prostatic Neoplasms; RNA, Messenger; Tumor Cells, Cultured | 2002 |
Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma.
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Contraceptives, Oral, Hormonal; Estradiol Congeners; Female; Folic Acid; Homocysteine; Humans; Male; Methionine; Prostatic Neoplasms; Risk Factors; Vitamin B 12 | 1992 |
[Folate status and urinary folate excretion in malignant disease].
Topics: Aged; Breast Neoplasms; Erythrocytes; Female; Folic Acid; Humans; Male; Middle Aged; Neoplasms; Prostatic Neoplasms | 1974 |
A reconsideration of the biology of carcinoma of the prostate.
Topics: Anemia; Biopsy, Needle; Castration; Cholesterol; Diethylstilbestrol; Estrogens; Folic Acid; Hematuria; Humans; Iron; Lipoproteins; Lymph Nodes; Male; Neoplasm Metastasis; Prostatectomy; Prostatic Neoplasms; Prostatitis; Testosterone; Triglycerides; Uremia; Urination Disorders; Vitamin B 12 | 1974 |